Gene Query: MCMBP

Dataset Description Geneva Score
EP400 is required for Max and MCPyV mediated gene activation 61.15
Genome wide expression change by RNF168 knocking down in NEC cells 59.53
Genome wide expression change by RNF168 knocking down in MCF-7 cells 50.16
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 38.81
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 38.81
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 37.1
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 35.19
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 33.61
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 29.48
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 26.32
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 25.85
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 25.55
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 25.35
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 24.05
RNA-seq analysis to identify the genes regulated by p53-SET interplay 22.95
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 22.72
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 22.64
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 22.33
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 22.33
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 22.26
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 21.53
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 20.25
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 20.19
Regulation of highly expressed hCINAP on translatome 19.04
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 18.96
RNAseq of HEK293 cells after Chtop knockdown 18.69
Co-transcriptional loading of RNA export factors shapes the human transcriptome 18.69
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 18.4
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 17.79
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 17.63
RIG-I and MDA5 fRIP during KSHV lytic reactivation 17.59
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 17.57
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 17.09
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 17.09
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 16.97
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 16.97
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 16.74
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 16.47
Differential expression of genes in AD169-infected MRC5. 16.27
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 16.1
Developmental stage specific chromosome architecture in human erythroid cells 15.78
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 15.78
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 15.77
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 15.7
Ribosomal footprinting of CN34-Parental and CN34-LM1a 15.68
The landscape of alternative splicing in aggressive prostate cancers 15.57
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 15.52
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 15.21
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 15.19
DART-seq: an antibody-free method for global m6A detection 15.11
A code of mono-phosphorylation modulates the function of RB. 15.09
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 14.96
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 14.84
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 14.82
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 14.53
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 14.46
Loss of CREBBP results in gene expression repression in lymphoma cells 14.44
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 14.44
RNA-seq of YB5 cells treated with Proscillaridin A 14.41
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 14.27
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 14.13
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 13.91
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 13.91
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 13.68
3’ Uridylation Expands miRNA Target Repertoire 13.63
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 13.61
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 13.5
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 13.47
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 13.46
Trans-differentiation of human adult peripheral blood T cells into neurons 13.45
TOP2B disturbed the quality of human oocytes with advanced maternal age 13.41
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 13.39
Seletive inhibition of CDK9 in DLBCL cell lines 13.31
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 13.2
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 13.17
Identification of Sin3B regulated genes during quiescence 13.13
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 13.13
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 13.13
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 13.06
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 12.99
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 12.94
Ribosomal footprinting of MDA-Parental and MDA-LM2 12.84
Effect of CHKA knockdown on C4-2 cell transcriptome 12.79
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 12.77
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 12.71
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 12.71
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 12.71
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 12.66
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 12.66
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 12.52
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 12.49
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 12.48
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 12.38
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 12.26
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 12.21
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 12.15
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 11.95
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 11.89
PTHrP overexpression in MCF7 cells 11.77
Gene expression changes caused by KRAS in MCF-10A 11.68
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 11.65
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 11.62
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 11.62
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 11.62
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 11.45
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 11.44
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 11.35
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 11.31
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 11.24
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 11.2
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 11.15
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 11.09
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 10.97
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 10.94
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 10.93
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 10.91
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 10.91
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 10.86
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 10.84
RNA-seq of shEZH2 cells 10.81
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 10.8
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 10.64
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 10.54
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 10.54
Paxillin regulates genomic networks in prostate cancer [LNCaP] 10.48
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 10.43
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 10.42
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 10.41
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 10.35
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 10.35
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 10.34
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 10.31
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 10.28
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 10.28
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 10.2
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 10.19
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 10.1
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 10.06
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 10.06
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 10.04
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 10.04
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 9.91
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 9.91
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 9.91
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 9.9
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 9.89
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 9.84
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 9.82
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 9.75
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 9.74
Identification of HOXB13 target genes responsive to BET inhibitors 9.74
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 9.71
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 9.67
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 9.67
Transcriptome analysis of U87 cells upon LINC00152 knockdown 9.66
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 9.48
Regulating Interleukin-2 activity with engineered receptor signaling clamps 9.46
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 9.43
Conservative alteration of chromosomal expression pattern across human solid tumor types 9.37
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 9.33
Small-molecule targeting of brachyury transcription factor addiction in chordoma 9.26
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 9.24
LncRNA-GAS5 negative regulation of YAP-target genes expression 9.24
The regulartory role of ZCCHC24 in splicing machinery 9.21
Role of XRN2 ribonucleolytic activity in RNA metabolism 9.18
Gene expression analysis of dengue-infected cells 9.17
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 9.15
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 9.02
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 9.02
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 8.97
An RNA-centric dissection of host complexes controlling flavivirus infection 8.94
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 8.94
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 8.91
NR2F2 study 8.87
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 8.87
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 8.86
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 8.85
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 8.85
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 8.82
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 8.82
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 8.79
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 8.78
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 8.76
Transcriptome analysis of BAP1 knockout and restoration 8.76
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 8.72
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 8.71
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 8.68
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 8.67
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 8.62
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 8.61
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 8.6
RNA-seq analysis of differentiating human erythroblasts 8.59
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 8.59
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 8.51
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 8.47
AR-independent prostate cancer is sustained through FGF signaling 8.43
Overexpression and knockdown experiment for circCSNK1G3 8.42
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 8.42
SLAM-seq for K562 endogenous mRNA decay 8.35
Crizotinib v. DMSO in SW480 cells 8.33
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 8.32
RNA-Seq with and without RNase treatment in PCa cell lines 8.29
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 8.25
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 8.24
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 8.21
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 8.16
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 8.1
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 8.1
hnRNP C is a key regulator of protein synthesis in mitosis 8.1
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 8.09
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 7.98
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 7.98
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 7.97
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 7.97
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 7.96
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 7.94
Fbxo32 mediated gene expression program underlies EMT and metastasis 7.93
Effect of mitochondria deficiency on senescence-associated gene expression 7.93
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 7.93
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 7.92
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 7.92
Inhibition of TNBC metastasis by Gpx1 7.81
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 7.8
MYC dependent mRNA translation shapes gene expression and cell biology 7.79
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 7.78
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 7.73
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 7.67
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 7.66
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 7.65
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 7.65
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 7.64
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 7.58
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 7.55
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 7.55
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 7.52
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 7.51
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 7.51
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 7.5
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 7.45
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 7.44
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 7.44
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 7.43
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 7.43
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 7.41
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 7.4
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 7.4
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 7.39
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 7.38
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 7.38
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 7.37
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 7.37
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 7.34
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 7.31
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 7.31
Mitochondrial dsRNA triggers antiviral signalling in humans 7.31
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 7.3
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 7.28
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 7.27
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 7.27
Genome-wide transcriptional response to random aneuploidy in human cells 7.26
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 7.25
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 7.21
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 7.19
RNA transcriptome analysis during HSV-1 infection 7.08
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 7.08
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 7.08
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 7.07
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 7.06
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 7.04
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 7.03
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 7.03
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 7.03
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 7.0
Expression profiling of etoposide-induced senescent cells 6.94
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 6.89
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 6.88
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 6.86
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 6.86
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 6.81
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 6.78
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 6.78
Zika infected neural stem cells 6.72
Transcriptome analysis of Zika infected neural stem cells 6.72
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 6.71
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 6.69
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 6.69
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 6.63
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 6.6
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 6.53
Differential Protein Occupancy Profiling of the mRNA Transcriptome 6.51
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 6.51
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 6.5
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 6.5
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 6.49
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 6.49
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 6.49
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 6.47
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 6.46
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 6.41
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 6.41
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 6.4
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 6.4
Role for citron kinase in prostate cancer growth 6.35
Transcriptional profile in human S. haematobium infection 6.3
Mechanistic Model-Guided Study of Embryonic Morphogenesis 6.29
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 6.28
Noncoding regions are the main source of targetable tumor-specific antigens 6.23
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 6.23
Aneuploidy-induced cellular stresses limit autophagic degradation. 6.21
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 6.18
Human cell line and subcutaneous tumor 6.14
Knockdown of ADNP in HCT116 colon cancer cells 6.13
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 6.07
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 6.06
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 5.98
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 5.94
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 5.9
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 5.89
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 5.88
RNA-Seq in neutrophils from Antiphospholipid Syndrome 5.77
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 5.74
Gene expression regulated by CSA and CSB in neuroblastoma cell line 5.72
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 5.7
TAF1 is critical for AE driven leukemogenesis 5.7
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 5.68
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 5.63
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 5.63
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 5.57
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 5.57
HBEC-shp53-PCHD7 5.49
METTL3 and WTAP 5.48
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 5.48
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 5.47
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 5.47
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 5.43
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 5.42
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 5.42
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 5.32
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 5.24
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 5.24
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 5.23
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 5.18
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 5.16
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 5.13
The transcriptome effect of overexpressing EZH2 in MCF7 5.13
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 5.08
6mer seed toxicity in tumour suppressive microRNAs 5.08
Ro60-knockout cells 5.01
MCF10A H-Ras RNA-Seq 4.99
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 4.87
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 4.86
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 4.86
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 4.83
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 4.82
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 4.76
Zone dependent distinctive gene expression profile of the normal human liver tissue 4.74
MAIT cell RNA sequencing 4.72
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 4.71
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 4.66
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 4.65
RNA-seq of RKO cells with cTAZ KO or putback 4.64
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 4.64
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 4.57
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 4.53
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 4.51
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 4.39
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 4.37
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 4.34
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 4.3
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 4.26
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 4.22
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 4.21
An siRNA screen identifies CHD4 as a target for epigenetic therapy 4.19
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 4.15
CDK12 mediated transcriptional regulation in U2OS cells 4.15
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 4.13
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 4.02
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 3.94
Copper Regulation of HIF-1 Transcription Activity 3.94
Human cells contain natural double-stranded RNAs with potential regulatory capacity 3.9
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.9
BACH2 in human plasma cell fate decision 3.89
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 3.89
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 3.85
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.7
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 3.67
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 3.67
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 3.67
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 3.57
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.56
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 3.53
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 3.52
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 3.47
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 3.44
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 3.39
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 3.31
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 3.25
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.25
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 3.12
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 3.12
Ribosome profiling upon inhibition of eIF4A 3.12
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 3.11
FOXP2's impact on the primate transcriptome 3.03
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 3.02
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 2.95
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 2.87
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 2.87
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 2.84
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 2.82
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 2.76
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 2.73
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 2.65
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 2.64
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.64
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 2.58
6mer seed toxicity in viral microRNAs 2.55
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 2.52
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 2.52
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 2.51
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 2.42
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 2.42
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 2.41
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.38
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 2.36
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 2.35
Transcriptome analysis upon C6orf203 silencing 2.35
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.32
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 2.3
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 2.3
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 2.26
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 2.25
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.21
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.21
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 2.19
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 2.18
Defective structural RNA processing in relapsing-remitting multiple sclerosis 2.14
Regulatory network controlling tumor-promoting inflammation in human cancers 2.06
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 2.06
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.96
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.96
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.92
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.92
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.92
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.91
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.83
Retinoic acid suppresses MYB in adenoid cystic carcinoma 1.8
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 1.8
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.79
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.75
Finding missing proteins from epigenetically manipulated human cells 1.7
EGR1-controlled transcriptome of T HESCs 1.67
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 1.66
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 1.66
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 1.55
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 1.55
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.51
Transposon-based construction of strand-specific RNA-seq libraries 1.49
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.41
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.4
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.4
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 1.38
ADAR1-editing of cellular and measles virus-derived duplex RNA 1.24
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 1.24
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 1.23
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 1.23
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.1
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 1.0
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.96
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 0.94
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.86
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 0.77
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.76
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.76
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 0.73
Identification of the role of polydom in neurofibromas 0.73
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.69
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.69
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.69
Dermal endothelial cells of type 2 diabetic patients 0.67
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.59
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.55
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.52
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 0.52
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.49
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.49
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.48
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.47
Transcription elongation regulates genome 3D structure 0.47
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.45
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.44
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.24
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.21
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.21
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.19
Expression analysis of the TAF1 syndrome 0.09
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.08
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.06
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.06
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.02
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation